0000000000241450

AUTHOR

Rolando Herrero

showing 10 related works from this author

Does Family History of Cancer Influence Undergoing Screening and Gastrointestinal Investigations?

2020

Background and Aims: Although a family history of cancer (FHC) can modify the lifestyle and attitudes towards participation in cancer screening programs, studies on this relationship show mixed results and vary across populations. The objectives of the study were to compare sociodemographic characteristics, history of gastrointestinal (GI) investigations and Helicobacter pylori eradication, and modifiable cancer risk factors between those with FHC and those with no FHC (NFHC), and to investigate the association between FHC and a history of GI investigations.
 Methods: A total of 3,455 questionnaires from the pilot study of the “Helicobacter pylori eradication and pepsinogen testing for…

Malemedicine.medical_specialtyHealth BehaviorColonoscopyPilot ProjectsLogistic regressionHelicobacter InfectionsScreening programmeRisk FactorsInternal medicineSurveys and QuestionnairesCancer screeningmedicineHumanscardiovascular diseasesFamily historyMedical History TakingEarly Detection of CancerGastrointestinal Neoplasmsbiologymedicine.diagnostic_testHelicobacter pyloribusiness.industryGastroenterologyCancerFaecal occult bloodColonoscopyHelicobacter pyloriPatient Acceptance of Health Caremedicine.diseasebiology.organism_classificationLatviaSocioeconomic FactorsFemalebusinessJournal of gastrointestinal and liver diseases : JGLD
researchProduct

Multicentric randomised study ofHelicobacter pylorieradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study

2017

IntroductionPopulation-based eradication ofHelicobacter pylorihas been suggested to be cost-effective and is recommended by international guidelines. However, the potential adverse effects of widespread antibiotic use that this would entail have not been sufficiently studied. An alternative way to decrease gastric cancer mortality is by non-invasive search for precancerous lesions, in particular gastric atrophy; pepsinogen tests are the best currently available alternative. The primary objective of GISTAR is to determine whetherH pylorieradication combined with pepsinogen testing reduces mortality from gastric cancer among 40–64-year-old individuals. The secondary objectives include evaluat…

Research designmedicine.medical_specialtyeducation.field_of_studyPepsinogen Abiologybusiness.industryStomachPopulationCancerGeneral MedicineHelicobacter pyloribiology.organism_classificationmedicine.diseaseSurgery03 medical and health sciences0302 clinical medicinemedicine.anatomical_structure030220 oncology & carcinogenesisInternal medicinemedicine030211 gastroenterology & hepatologyMedical historyAdverse effecteducationbusinessBMJ Open
researchProduct

Accuracy of two plasma antibody tests and faecal antigen test for non-invasive detection of H. pylori in middle-aged Caucasian general population sam…

2018

The aim of the study was to assess the accuracy of two plasma Helicobacter pylori (H. pylori) antibody test-systems and a stool antigen test (SAT) system in a general population sample in Latvia.Blood and faecal samples were analysed in healthy individuals (40-64 years), referred for upper gastrointestinal endoscopy according to pilot study protocol within a population-based study investigating gastric cancer prevention strategies (GISTAR pilot study). Antibodies to H. pylori were assessed in plasma by latex-agglutination test and enzyme-linked immunosorbent assay (ELISA). H. pylori antigen in faecal samples was detected by a monoclonal enzyme immunoassay-based SAT. Histological assessment …

AdultMalePopulation sampleEnzyme-Linked Immunosorbent AssayPilot ProjectsSensitivity and SpecificityHelicobacter Infections03 medical and health sciencesFeces0302 clinical medicineMedicineHumansSerologic TestsAntigens BacterialbiologyHelicobacter pyloribusiness.industryNon invasiveGastroenterologyHelicobacter pyloriMiddle Agedbacterial infections and mycosesbiology.organism_classificationAntigen testAntibodies BacterialLatex fixation testROC Curve030220 oncology & carcinogenesisImmunologybiology.proteinStool antigen030211 gastroenterology & hepatologyFemaleFranceAntibodybusinessScandinavian journal of gastroenterology
researchProduct

Sociodemographic, Lifestyle and Medical Factors Associated with Helicobacter Pylori Infection

2020

Background and Aims: The prevalence of Helicobacter pylori (H. pylori) infection is higher in developing countries and is often linked to lower socioeconomic status. Few studies have investigated the association between H. pylori and individual level characteristics in Europe, where several countries have a high prevalence of H. pylori infection. The study aimed to identify risk factors for H. pylori infection among adults in a large clinical trial in Latvia.
 Methods: 1,855 participants (40-64 years) of the “Multicenter randomized study of H. pylori eradication and pepsinogen testing for prevention of gastric cancer mortality” (GISTAR study) in Latvia tested for H. pylori IgG antibodi…

AdultMalemedicine.medical_specialtySocial Determinants of HealthBinge drinkingDiseaseRisk AssessmentBinge DrinkingHelicobacter Infectionslaw.inventionRandomized controlled trialRisk FactorslawInternal medicinemedicineHumansLife StyleSocioeconomic statusRandomized Controlled Trials as TopicUnivariate analysisHelicobacter pyloribiologybusiness.industrySmokingGastroenterologyOdds ratioMiddle AgedHelicobacter pyloribiology.organism_classificationLatviaDietClinical trialCross-Sectional StudiesSocioeconomic FactorsFemalebusinessJournal of Gastrointestinal and Liver Diseases
researchProduct

Prevalence and Potential Risk Factors of Helicobacter pylori Infection among Asymptomatic Individuals in Kazakhstan

2021

Background: Helicobacter pylori (H. pylori) infection is associated with several risk factors such as demographic, socioeconomic status and personal habits, which vary in different populations. This is the most up-to-date data on H. pylori prevalence and potential risk factors for H. pylori infection among asymptomatic middle-aged individuals in Kazakhstan. Methods: Apparently healthy individuals aged 40 to 64, who took part in the health control in the outpatient clinic, were invited to participate in the study; answered a questionnaire, donated a blood sample. The antibodies to H. pylori were analysed by latex agglutination method. The baseline characteristics of study subjects with or wi…

0301 basic medicineAdultMalemedicine.medical_specialtyprevalenceLogistic regressionAsymptomaticHelicobacter Infections03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineOdds RatioOutpatient clinicHumansSalt intakeAsymptomatic InfectionsbiologyHelicobacter pyloribusiness.industrygastric cancerAge FactorsGeneral MedicineOdds ratioAnthropometryHelicobacter pyloriMiddle Agedbiology.organism_classificationConfidence intervalKazakhstanDiet030104 developmental biologyLogistic ModelsSocioeconomic Factors030220 oncology & carcinogenesisFemalemedicine.symptombusinessResearch ArticleAsian Pacific Journal of Cancer Prevention : APJCP
researchProduct

How do international gastric cancer prevention guidelines influence clinical practice globally?

2020

Clinical guidelines recommend particular approaches, including 'screen-and-treat' strategy for Helicobacter pylori, to prevent gastric cancer. However, little of this is implemented in clinical practice. The aim of the study was to identify barriers to implementation of international guidelines. A web-based questionnaire distributed globally to specialists in the field. Altogether 886 responses from 75 countries were received. Of the responders, 570 (64%) were men of mean age 47 years. There were 606 gastroenterologists and 65 epidemiologists among the responders. Altogether, 79.8% of the responders disagreed that the burden of gastric cancer is a diminishing problem. 'Screen-and-treat' str…

AdultMaleCancer Researchmedicine.medical_specialtyEpidemiologyPopulationMEDLINEHelicobacter Infections03 medical and health sciencesYoung Adult0302 clinical medicineSDG 3 - Good Health and Well-beingStomach NeoplasmsSurveys and QuestionnairesmedicineHumans030212 general & internal medicinePractice Patterns Physicians'educationEarly Detection of CancerAgedAged 80 and overeducation.field_of_studybiologyHelicobacter pyloribusiness.industryGastric cancer preventionUpper endoscopyPublic Health Environmental and Occupational HealthCancerInternational AgenciesHelicobacter pyloriMiddle Agedmedicine.diseasebiology.organism_classificationPrognosis3. Good healthClinical PracticeVaccinationSurvival RateOncology030220 oncology & carcinogenesisFamily medicinePractice Guidelines as Topic/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemalebusinessEuropean journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
researchProduct

Regional variations in Helicobacter pylori infection, gastric atrophy and gastric cancer risk: The ENIGMA study in Chile.

2020

International audience; Background: Regional variations in gastric cancer incidence are not explained by prevalence of Helicobacter pylori, the main cause of the disease, with several areas presenting high H. pylori prevalence but low gastric cancer incidence. The IARC worldwide H. pylori prevalence surveys (ENIGMA) aim at systematically describing age and sex-specific prevalence of H. pylori infection around the world and generating hypotheses to explain regional variations in gastric cancer risk.Methods: We selected age- and sex-stratified population samples in two areas with different gastric cancer incidence and mortality in Chile: Antofagasta (lower rate) and Valdivia (higher rate). Pa…

MaleEpidemiologyPathology and Laboratory MedicineGastroenterologyGeographical locations0302 clinical medicineRisk FactorsHelicobacterEpidemiology of cancerPrevalenceMedicine and Health SciencesMedicineChileEnzyme-Linked ImmunoassaysYoung adultChildeducation.field_of_studyMultidisciplinary[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologybiologyCancer Risk FactorsStomachQRMiddle AgedBacterial Pathogens3. Good healthOncologyMedical MicrobiologyChild Preschool030220 oncology & carcinogenesisMedicineFemale030211 gastroenterology & hepatologyPathogensCancer EpidemiologyResearch ArticleAdultmedicine.medical_specialtyAdolescentSciencePopulationResearch and Analysis MethodsMicrobiologyHelicobacter InfectionsYoung Adult03 medical and health sciencesSigns and SymptomsAtrophyStomach NeoplasmsInternal medicineGastrointestinal TumorsHumansCagASeroprevalenceImmunoassayseducationMicrobial PathogensAgedChile (Country)Bacteriabusiness.industryOrganismsInfantBiology and Life SciencesCancers and NeoplasmsCancerSouth AmericaHelicobacter pylorimedicine.diseasebiology.organism_classificationHelicobacter Pyloridigestive system diseasesGastric CancerAge GroupsMedical Risk FactorsPeople and PlacesImmunologic TechniquesPopulation GroupingsClinical MedicineAtrophybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyPLoS ONE
researchProduct

Prevalence of Atrophic Gastritis in Kazakhstan and the Accuracy of Pepsinogen Tests to Detect Gastric Mucosal Atrophy

2019

Background Atrophic gastritis is considered precursor condition for gastric cancer. There is so far limited evidence on the performance of pepsinogens for atrophy detection in Central Asia. The aim of our study was to detect the prevalence of atrophic gastritis in the asymptomatic adult population in Kazakhstan as well as address the accuracy of pepsinogen testing in atrophy detection. Methods Healthy individuals aged 40-64 were included. Upper endoscopy and pepsinogens (PG) evaluation were performed. PG were analysed in plasma by latex agglutination. Cut off values were used to define decreased PG values (PGR ≤ 3 and PG I ≤ 70 ng/mL); severely decreased PG values (PGR ≤ 2 and PG I ≤ 30 ng/…

AdultGastritis AtrophicMale0301 basic medicinemedicine.medical_specialtyAtrophic gastritisPopulationgastricAsymptomaticGastroenterology03 medical and health sciences0302 clinical medicineAtrophyatrophyPepsinPepsinogen AInternal medicinePrevalenceHumansMedicineeducationeducation.field_of_studyPepsinogensbiologyatrophicbusiness.industrygastric cancerscreeninggastritisEndoscopyGeneral MedicineGold standard (test)Middle AgedPrognosismedicine.diseaseKazakhstanLatex fixation test030104 developmental biologyROC CurveGastric Mucosa030220 oncology & carcinogenesisbiology.proteinFemaleGastritismedicine.symptombusinessResearch ArticleFollow-Up StudiesAsian Pacific Journal of Cancer Prevention
researchProduct

Accuracy of two plasma antibody tests and faecal antigen test for non-invasive detection of H. pylori in middle-aged Caucasian general population sam…

2018

Objective: The aim of the study was to assess the accuracy of two plasma Helicobacter pylori (H. pylori) antibody test-systems and a stool antigen test (SAT) system in a general population sample in Latvia. Materials and methods: Blood and faecal samples were analysed in healthy individuals (40–64 years), referred for upper gastrointestinal endoscopy according to pilot study protocol within a population-based study investigating gastric cancer prevention strategies (GISTAR pilot study). Antibodies to H. pylori were assessed in plasma by latex-agglutination test and enzyme-linked immunosorbent assay (ELISA). H. pylori antigen in faecal samples was detected by a monoclonal enzyme immunoassay-…

researchProduct

European code against cancer 4th edition: 12 ways to reduce your cancer risk

2015

AbstractThis overview describes the principles of the 4th edition of the European Code against Cancer and provides an introduction to the 12 recommendations to reduce cancer risk. Among the 504.6 million inhabitants of the member states of the European Union (EU28), there are annually 2.64 million new cancer cases and 1.28 million deaths from cancer. It is estimated that this cancer burden could be reduced by up to one half if scientific knowledge on causes of cancer could be translated into successful prevention. The Code is a preventive tool aimed to reduce the cancer burden by informing people how to avoid or reduce carcinogenic exposures, adopt behaviours to reduce the cancer risk, or t…

Cancer Researchmedicine.medical_specialtyQuality Assurance Health CareEpidemiologyUterine Cervical NeoplasmsCancer preventionCauses of cancerCancer screeningBreast cancerRisk FactorsEnvironmental healthCancer screeningmedicinemedia_common.cataloged_instanceHumansEuropean UnionEuropean unionPreventive healthcaremedia_commonCervical cancerCancer risk factorsCancer preventionbusiness.industryCancermedicine.diseaseEuropeOncology1117 Public Health And Health ServicesWorking Groups of Scientific ExpertsPractice Guidelines as TopicFemalebusiness1112 Oncology And Carcinogenesis
researchProduct